Respiratory - Antibody (4)
|
Modality |
Indication |
Targets |
Stage |
Company |
Project No. |
Detail |
| 1 |
Development of a first-in-class therapeutic antibody lead targeting GTC-D1 for pulmonary fibrosis |
| Antibody |
IPF |
GTC-D1 |
Hit |
Good T cells, Inc. |
RS-2025-25455100 |
|
| 2 |
Development of CSF3 targeted Pre-clinical Candidate Human Monoclonal Antibody FB-101 for Pulmonary Fibrosis |
| Antibody |
Idiopathic Pulmonary Fibrosis |
CSF3 |
Candidate |
FNCT Biotech, Inc. |
RS-2024-00461975 |
|
| 3 |
Development of therapeutic fully human monoclonal antibody FBPF-11X as lead compound for pulmonary fibrosis |
| Antibody |
Pulmonary fibrosis |
FBFP-101-T |
Lead |
FNCT Biotech |
HN22C0683 |
|
| 4 |
Development of antibodies to induce lung regeneration for the treatment of emphysema |
| Antibody |
Pulmonary emphysema |
Robo1 |
Hit |
Asan Medical Center |
HN21C0202 |
|